No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapyK.M. Robinson, Sima Jeha, Seth E. Karol et al.|Pediatric Blood & Cancer|2019Cited by 10